Loading...

Sustained Demand For Nutrition And Dairy Will Drive Global Market Gains

Published
02 Mar 25
Updated
11 Dec 25
Views
56
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
17.8%
7D
1.3%

Author's Valuation

€79.022.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 11 Dec 25

BN: Protein Dairy And China Nutrition Momentum Will Support Steady Returns Ahead

Analysts have modestly increased their price target for Danone, citing a series of recent target hikes to the mid EUR 70s to low EUR 80s range, along with growing confidence that improving trends in protein dairy and China Specialized Nutrition can support a more sustainable growth trajectory.

Analyst Commentary

Recent research updates reflect a generally constructive stance on Danone, with multiple price target increases signaling greater confidence in the company’s medium term growth prospects and execution.

Bullish Takeaways

  • Bullish analysts highlight the upgrade to a Buy rating alongside a significant price target increase into the mid EUR 80s, indicating improved confidence in Danone’s valuation upside as earnings visibility strengthens.
  • Stronger than expected momentum in protein dairy and China Specialized Nutrition is viewed as a structural growth driver, supporting a more durable top line acceleration and margin improvement over time.
  • Incremental price target raises into the mid EUR 70s to low EUR 80s range are seen as a reflection of better execution, with expectations for a more sustainable growth run rate than previously assumed.
  • Improving trends in key strategic categories are interpreted as evidence that prior portfolio and efficiency initiatives are beginning to translate into higher quality, more consistent earnings growth.

Bearish Takeaways

  • Bearish analysts, while lifting price targets, are retaining more neutral ratings, signaling lingering concerns that current valuations may already discount much of the anticipated operational improvement.
  • Ongoing challenges in creamers are cited as a drag on overall performance, creating execution risk if category headwinds persist longer than expected and offset gains in higher growth segments.
  • Despite better trends in China Specialized Nutrition, some caution remains around exposure to China, where demand volatility and regulatory shifts could pressure the pace and consistency of growth.
  • There is residual skepticism about the durability of the new growth run rate, with some investors wary that a weaker global consumer backdrop could limit Danone’s ability to fully realize its upgraded earnings potential.

What's in the News

  • Tata Consumer Products is in advanced talks to acquire Danone's India nutraceuticals and specialised nutrition portfolio, giving Tata a stronger foothold in wellness and value added nutrition while Danone potentially streamlines its regional portfolio (Key Developments)
  • Danone confirmed 2025 guidance, targeting like for like sales growth of 3% to 5% and recurring operating income growth faster than sales, indicating management confidence in margin and earnings improvement (Key Developments)
  • Danone and ARGAN began construction of a new Aut0nom logistics site in Sorigny, which will double Danone's logistics capacity in France's Greater West and incorporate on site green energy for more sustainable cold chain operations (Key Developments)

Valuation Changes

  • Fair Value: Unchanged at approximately €79.0 per share, indicating no revision to the central valuation estimate.
  • Discount Rate: Essentially stable at about 6.18%, implying no meaningful change in the risk profile applied to future cash flows.
  • Revenue Growth: Steady at around 3.0% annually, reflecting unchanged expectations for Danone’s top line expansion.
  • Net Profit Margin: Effectively unchanged at roughly 9.3%, suggesting stable assumptions for long term profitability.
  • Future P/E: Flat at about 21.8x, indicating no adjustment to the valuation multiple applied to forward earnings.

Key Takeaways

  • Focus on innovation, health-driven products, and strategic acquisitions solidifies Danone's leadership in premium nutrition and specialty segments amid changing consumer preferences.
  • Expanding in emerging markets and shifting towards digital and healthcare channels enhances growth opportunities, operational efficiency, and long-term margin stability.
  • Reliance on legacy products, operational inefficiencies, acquisition integration risks, currency volatility, and cost pressures from supply and regulation threaten Danone's sustained revenue and margin growth.

Catalysts

About Danone
    Operates in the food and beverage industry in Europe, Ukraine, North America, China, North Asia, the Oceania, Latin America, rest of Asia, Africa, Turkey, the Middle East, and the Commonwealth of Independent States.
What are the underlying business or industry changes driving this perspective?
  • Continued innovation and expansion in health-driven, functional foods and specialized nutrition-such as high-protein, probiotic, and medical nutrition products-positions Danone to capture above-market revenue growth as global consumers become increasingly focused on wellness and science-based nutrition.
  • Geographic broadening in emerging markets, especially across Asia, Africa, and Latin America, leverages rising urbanization and the growing middle class to expand Danone's addressable market and drive long-term revenue and volume gains.
  • Strategic investments and recent acquisitions (Kate Farms, The Akkermansia Company) strengthen Danone's leadership in plant-based, gut health, and medical nutrition, reinforcing differentiation and supporting both premiumization (higher revenue per unit sold) and improved long-term margin potential.
  • Early supply chain digitalization and increased operational productivity-evidenced by best-in-class manufacturing upgrades and cost discipline-are set to drive efficiency gains and support sustainable margin expansion, improving recurring operating income and overall earnings.
  • Shifting channel mix towards higher-growth segments, such as online/direct-to-consumer and specialized healthcare distribution, is expected to reduce reliance on traditional retail, increase brand control, and lift net margins and earnings resilience over time.

Danone Earnings and Revenue Growth

Danone Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Danone's revenue will grow by 3.0% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 6.7% today to 9.1% in 3 years time.
  • Analysts expect earnings to reach €2.7 billion (and earnings per share of €4.25) by about September 2028, up from €1.8 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €2.4 billion.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 21.1x on those 2028 earnings, down from 26.1x today. This future PE is greater than the current PE for the GB Food industry at 11.4x.
  • Analysts expect the number of shares outstanding to decline by 0.08% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 5.98%, as per the Simply Wall St company report.

Danone Future Earnings Per Share Growth

Danone Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Danone continues to rely heavily on traditional dairy and bottled water segments, and while functional and high-protein innovations are growing, slow improvement and inconsistent leadership in core categories, particularly dairy in major markets like the U.S. and Europe, could constrain long-term revenue growth if consumer trends shift further towards fresh, unprocessed, and locally sourced foods.
  • Structural challenges remain in North America, including execution issues and lagging plant-based brand performance (Silk), coupled with frustration from management about the speed of turnaround; this suggests ongoing operational inefficiencies and leadership uncertainty, which may suppress net margins and earnings if not fully resolved.
  • While Danone's recent acquisitions (e.g., Kate Farms, Akkermansia) show promise, there are inherent execution risks involved in integrating these businesses and extracting synergies-failure to successfully leverage these deals or deliver innovation at pace could result in one-off charges and increased volatility in earnings.
  • Persistent foreign exchange headwinds, particularly euro appreciation against the U.S. dollar and Chinese renminbi, have already offset like-for-like revenue growth, and ongoing currency volatility poses a material risk to both reported revenues and net profits, especially given Danone's broad geographic footprint.
  • Commodity and ingredient price volatility, exacerbated by climate change and global supply chain disruptions, remains a risk for Danone's cost of goods sold; combined with potential regulatory changes targeting plastics and carbon emissions, this could increase operating costs and ultimately erode margins if not proactively managed.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of €74.914 for Danone based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €85.0, and the most bearish reporting a price target of just €62.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €29.9 billion, earnings will come to €2.7 billion, and it would be trading on a PE ratio of 21.1x, assuming you use a discount rate of 6.0%.
  • Given the current share price of €74.32, the analyst price target of €74.91 is 0.8% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Danone?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives